Aurobindo Pharma receives USFDA approval for generic glycerol phenylbutyrate oral liquid to treat urea cycle disorders.

Aurobindo Pharma Limited has received final approval from the United States Food and Drug Administration (USFDA) for Glycerol ...

Guidance opens doors for rare disease treatments, but academic teams will likely need industry partners to meet rigor required for FDA approval Following up on their previous work with the FDA on UCDs ...

Aurobindo Pharma Ltd has achieved final approval from the USFDA to produce and distribute a generic glycerol phenylbutyrate oral liquid, intended to manage high blood ammonia levels due to urea cycle ...

Two Philadelphia doctors who led the groundbreaking gene-editing treatment of baby boy from Delaware County are included ...

Aurobindo Pharma has secured USFDA approval for its generic glycerol phenylbutyrate oral liquid, strengthening its product ...

Aurobindo Pharma Ltd on Friday said it has received final approval from the US health regulator to manufacture and market its ...

According to IQVIA data cited by the company, the product has an estimated market size of $50.2 million for the 12 months ...

Aurobindo Pharma announced the receipt of the final approval from the US Food & Drug Administration (USFDA) to manufacture and market Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per mL, which is ...

Aurobindo Pharma announced that it has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Glycerol Phenylbutyrate Oral Liquid, 1.1 grams per ml.